P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer

Triple-negative breast cancer--current status and future directions

(2009) O. Gluz et al.   ANNALS OF ONCOLOGY

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situhybridization (FISH): pathologist assessment compared to quantitative image analysis

(2009) Gulisa Turashvili et al.   BMC CANCER

Functional characterization of E- and P-cadherin in invasive breast cancer cells

(2009) David Sarrió et al.   BMC CANCER

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

(2009) Shuzhen Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells

(2009) A S Ribeiro et al.   ONCOGENE

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

(2008) Azza Ben Hamida et al.   BMC CANCER

New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up

(2008) K. C. Jensen et al.   BREAST CANCER RESEARCH AND TREATMENT

Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer

(2008) Ferdinando Mannello et al.   CANCER SCIENCE

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

(2008) K. Imai et al.   CLINICAL CANCER RESEARCH

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Reporting Bias in Diagnostic and Prognostic Studies: Time for Action

(2008) N. Rifai et al.   CLINICAL CHEMISTRY

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1

(2008) J B Arnes et al.   HISTOPATHOLOGY

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes

(2008) J S Reis-Filho et al.   HISTOPATHOLOGY

Expression of BRCA1 protein in breast cancer and its prognostic significance

(2008) Emad A. Rakha et al.   HUMAN PATHOLOGY

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer

(2008) J B Arnes et al.   JOURNAL OF CLINICAL PATHOLOGY

Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival

(2008) J Paredes et al.   JOURNAL OF CLINICAL PATHOLOGY

Tissue Microarrays in Clinical Oncology

(2008) David Voduc et al.   SEMINARS IN RADIATION ONCOLOGY